We further performed IHC analysis in two Skip N2—Adenocarcinoma and two Non-Skip N2-Adenocarcinoma samples using E-cadherin and Vimentin antibodies in order to confirm our PCR results. Here, CDH1 is linked to adenocarcinoma.